Archives for January 12, 2004

← 2004

Merck deal backs BASF IT Services' independence

BASF IT Services, one of the first units of the German chemical major to be spun out into a separate unit, has signed an agreement with Merck KGaA that confirms its ability to win major contracts from companies other than its parent.

New route to epoxides from Bayer

Bayer Fine Chemicals has developed a new way to make chiral epoxides that could shorten reaction times and reduce the amount of expensive catalysts used in the process.

Altana to break ground on Cork facility

German pharmaceutical company Altana has started construction of a €70 million manufacturing facility in Cork, Ireland. The move would appear to refute claims that the attractiveness of the region to the drug industry is on the wane.

New hands on the helm at UK's TAP

The Automation Partnership (TAP), a company specialising in the application of robotics to pharmaceutical drug discovery and production, has named a new chief executive to succeed Richard Archer, who is stepping down in February.

Blocking tumour repair could improve therapy

Researchers in the UK have discovered a protein that seems to play a key role in repairing the DNA of cells. The discovery could lead to a way of inhibiting malignant cells from repairing themselves after treatment, potentially improving cancer therapy.

Pharma packaging set for continued growth

World pharmaceutical packaging demand will increase at a rate of 4.3 per cent a year to reach $22.2 billion (€17.2bn) in 2007, according to a new report from Freedonia Group. Companies supplying blister packaging will benefit from particularly strong...

First 'druggable' gene kit from Qiagen

Qiagen of the Netherlands has started shipping a set of RNA interference (RNAi) reagents that correspond to the 5,000 or so genes in the human genome thought most likely to be viable targets for drug discovery.

Small is beautiful for Genentech

Genentech's strategy of expanding beyond its traditional territory of protein-based drugs and into small molecules was reinforced earlier this week by its new agreement with Array BioPharma.

Great Lakes finds buyer for Halebank facility

UK independent Pentagon Chemicals has made its first major acquisition since spinning out of parent Dow Chemical in a management buyout in 2002, in a move which bolsters its product range and contract manufacturing capacity.